基于深度学习的HRCT预后预测在进展性纤维化性肺疾病中的应用
本研究评估深度学习算法SOFIA在HRCT上识别UIP样特征(UIP概率)的预后准确性,数据来自国家登记队列中特征明确的进展性纤维化性肺疾病患者。将SOFIA和放射科医生的UIP概率转换为PIOPED UIP概率分类,并用Cox比例风险模型评估预后效用。多变量分析校正年龄、性别、指南放射学诊断和疾病严重程度后,仅SOFIA UIP概率PIOPED分类预测生存。在放射科专家共识认为不确定的患者(n=83)中,SOFIA-PIOPED分类仍有预后意义(HR 1.73,P<0.0001,95%CI 1.40-2.14);在接受外科肺活检的患者(n=86)中,校正指南组织学模式和HRCT总ILD范围后,仅SOFIA-PIOPED概率预测死亡(HR 1.75,P<0.0001,95%CI 1.37-2.25)。结论认为深度学习UIP概率在HRCT上相比专家放射科评估或指南组织学模式提供增强的结局预测,原则上该工具可能有助于纤维化性肺疾病的多学科表征,但作为决策支持系统在缺乏ILD专业知识时的效用需进一步研究。
要点
- 多变量分析校正年龄、性别、指南放射学诊断和疾病严重程度后,仅SOFIA UIP概率PIOPED分类预测生存。
- 放射科专家共识不确定的患者(n=83)中,SOFIA-PIOPED UIP概率分类仍预测生存(HR 1.73,P<0.0001,95%CI 1.40-2.14)。
- 外科肺活检患者(n=86)中,校正指南组织学模式和HRCT总ILD范围后,仅SOFIA-PIOPED概率预测死亡(HR 1.75,P<0.0001,95%CI 1.37-2.25)。
- SOFIA-PIOPED UIP概率分类基于PIOPED:0-4%不包含UIP、5-29%低概率、30-69%中等概率、70-94%高概率、95-100%病理特征性。
- 作者认为该工具原则上可能有助于纤维化性肺疾病的多学科表征,但作为决策支持系统在缺乏ILD专业知识时的效用需进一步研究。
适用人群与场景
- 来自国家登记队列的特征明确的进展性纤维化性肺疾病患者。
- 放射科专家共识认为不确定的患者(n=83)。
- 接受外科肺活检的患者(n=86)。
诊断标准与关键阈值
- SOFIA和放射科医生UIP概率转换为PIOPED UIP概率分类:UIP不包含在鉴别诊断中,0-4%;低UIP概率,5-29%;中等UIP概率,30-69%;高UIP概率,70-94%;UIP病理特征性,95-100%。
研究设计与关键结果
- 研究评估深度学习算法SOFIA在HRCT上识别UIP样特征(UIP概率)的预后准确性,队列来自国家登记。
- 多变量分析校正年龄、性别、指南放射学诊断和疾病严重程度(HRCT总ILD范围、预测FVC百分比、DlCO或复合生理指数)后,仅SOFIA UIP概率PIOPED分类预测生存。
- 在放射科专家共识认为不确定的患者(n=83)中,SOFIA-PIOPED UIP概率分类仍具预后意义(HR 1.73;P<0.0001;95%CI 1.40-2.14)。
- 在接受外科肺活检的患者(n=86)中,校正指南组织学模式和HRCT总ILD范围后,仅SOFIA-PIOPED概率预测死亡(HR 1.75;P<0.0001;95%CI 1.37-2.25)。
证据类型、等级与局限
- 研究类型:预后预测模型评估,使用Cox比例风险模型。
- 局限:原文未报告局限性。
- 作者指出该技术作为决策支持系统在缺乏ILD专业知识时的效用需进一步研究。
对床旁实践的改变
- 作者认为深度学习UIP概率在HRCT上相比专家放射科评估或指南组织学模式提供增强的结局预测。
- 作者认为该工具原则上可能有助于纤维化性肺疾病的多学科表征。
- 作者指出该技术作为决策支持系统在缺乏ILD专业知识时的效用需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Reliable outcome prediction in patients with fibrotic lung disease using baseline high-resolution computed tomography (HRCT) data remains challenging. Objectives: To evaluate the prognostic accuracy of a deep learning algorithm (SOFIA [Systematic Objective Fibrotic Imaging Analysis Algorithm]), trained and validated in the identification of usual interstitial pneumonia (UIP)-like features on HRCT (UIP probability), in a large cohort of well-characterized patients with progressive fibrotic lung disease drawn from a national registry. Methods: SOFIA and radiologist UIP probabilities were converted to Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)-based UIP probability categories (UIP not included in the differential, 0-4%; low probability of UIP, 5-29%; intermediate probability of UIP, 30-69%; high probability of UIP, 70-94%; and pathognomonic for UIP, 95-100%), and their prognostic utility was assessed using Cox proportional hazards modeling. Measurements and Main Results: In multivariable analysis adjusting for age, sex, guideline-based radiologic diagnosis, anddisease severity (using total interstitial lung disease [ILD] extent on HRCT, percent predicted FVC, DlCO, or the composite physiologic index), only SOFIA UIP probability PIOPED categories predicted survival. SOFIA-PIOPED UIP probability categories remained prognostically significant in patients considered indeterminate (n = 83) by expert radiologist consensus (hazard ratio, 1.73; P < 0.0001; 95% confidence interval, 1.40-2.14). In patients undergoing surgical lung biopsy (n = 86), after adjusting for guideline-based histologic pattern and total ILD extent on HRCT, only SOFIA-PIOPED probabilities were predictive of mortality (hazard ratio, 1.75; P < 0.0001; 95% confidence interval, 1.37-2.25). Conclusions: Deep learning-based UIP probability on HRCT provides enhanced outcome prediction in patients with progressive fibrotic lung disease when compared with expert radiologist evaluation or guideline-based histologic pattern. In principle, this tool may be useful in multidisciplinary characterization of fibrotic lung disease. The utility of this technology as a decision support system when ILD expertise is unavailable requires further investigation.
参考来源
- Walsh SLF, Mackintosh JA, Calandriello L, et al. Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography. Am J Respir Crit Care Med. 2022. PMID: 35696341. doi:10.1164/rccm.202112-2684OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。